Am­gen is launch­ing three new late-stage tri­als for its long-act­ing obe­si­ty shot Mar­i­Tide, in­clud­ing one de­signed to test the drug in pa­tients switch­ing away from...

Sea­port Ther­a­peu­tics be­gan trad­ing as a pub­lic com­pa­ny on Fri­day af­ter ex­ec­u­tives rang the Nas­daq’s open­ing bell. Shares rose SP­TX more than 20%.

With a...

The FDA on Fri­day ap­provedPfiz­er and Arv­inas' drug vepdeges­trant for pa­tients with a cer­tain form of breast can­cer. But it’s un­clear how many will...

Mod­er­na said it's work­ing with US reg­u­la­tors to pro­vide post-mar­ket­ing da­ta on its Covid-19 vac­cines that could re­store their use to a wider group af­ter...

Af­ter hold­ing a ral­ly in April, Sam­sung Bi­o­log­ics union work­ers on Fri­day start­ed a five-day strike over wage ne­go­ti­a­tions.

Around 95% of the com­pa­ny's union...